Bel 20 cyclical stocks in good shape (Belgian equity debriefing)

January 20, 2021

18:09

The Brussels Stock Exchange managed to bounce back on Wednesday. Only three values ​​of the Bel 20 have failed to advance. Bitter pill for Mithras.

Quiet day for the Nice 20

which did not leave the positive territories for a moment on Wednesday to end with a rebound of 0.91%. A rise that brings the star index closer to 3,750 points.

A rain of recommendations fell on the Brussels coast. Example with the world’s number one beer, AB InBev (-0.20% to 56.24 euros)

which saw Investec raise its price target to 63 euros.

KBC

(+ 0.91% to 60 euros) took advantage of the recalibration operated by Kepler Cheuvreux, still selling on the value but who raised his target price to 46 euros. Deutsche bank invites its clients to keep KBC securities, but slightly downgrades its ambitions for the Belgian bank’s action to 60 euros.

UCB

(+ 0.79% at 87.04 euros) did not make waves despite the adjustment of the target price of Credit Suisse which goes to 90 euros against 83 euros previously with a recommendation still set at “neutral”.

The cyclical values ​​of Bel 20 led the dance. Aperam (+2,98%)

, Umicore (+2,17%)

or Solvay

(+ 0.91%) have long fought for the top of the day’s hikes.

Conversely, Colruyt

and Ageas

were among the few losers in the session.

Excluding Bel 20, the action Care Prorety Invest

was suspended for a good part of the day, the time to complete a private placement of the new shares issued. The real estate company specializing in the health sector carried out a capital increase of 42.1 million euros at a unit price of 24.81 euros as part of the acquisition of the care and housing services center with a group of assisted living accommodation “Résidence des Ardennes” on the Luxembourg border. When its listing resumed, the SIR lost ground to end the session down 3.35%.

Brussels investors also witnessed a serious stock market slump for Mithra

. The boss of biotech was interviewed by the police in connection with the Nethys case. The title lost more than 12% in the morning before reducing its loss to 5.21% at the close of markets.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.